Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Microdose therapy










Image Number 2 for United States Patent #6610652.

Methods for treating vascular conditions associated with localized imbalance in vascular tone, which are hypothesized to be largely due to elevated endothelin (ET) are provided. The methods involve administration of nitric oxide (NO), agents which are able to provide NO, such as NO donors, agents which activate guanyl cyclase, such as YC-1, or agents which prolong the actions of endogenous NO or cyclic guanosine monophosphate (cGMP; a 2nd messenger molecule), such as phosphodiesterase (PDE) inhibitors. According to the invention, such agents are administered in minimal doses or microdoses by any route known in the art, so as to provide dosages which are about one half to about one twentieth (1/2 to 1/20) of those known to induce vasodilation in "normal" circulations. The low doses of these agents effectively alleviate vascular conditions associated with a reduction in NO production or an attenuation of NO effect, by restoring balance in vascular tone while exerting almost no systemic effect in normal vasculature.








 
 
  Recently Added Patents
System and method for the analysis of biodiesel
Electric vehicle charging station parking meter systems
Interconnecting virtual domains
Relative pose estimation of non-overlapping cameras using the motion of subjects in the camera fields of view
Apparatus and method for layered decoding in a communication system using low-density parity-check codes
Malicious attack detection and analysis
Gaze tracking password input method and device utilizing the same
  Randomly Featured Patents
Network control apparatus for controlling devices composing comunication network including the apparatus
Scent delivery device
Baseball or golf hat
Reaction tube
Cup
VCO pre-compensation
Composite solid particle and method for producing same
Clip for bags
Distributed video coding apparatus and method capable of controlling encoding rate
N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents